Patient and genetic counselor perceptions of in-person versus telephone genetic counseling for hereditary breast/ovarian cancer
Aryana Jacobs(Georgetown University), Beth N. Peshkin(Georgetown University), Rachel Nusbaum(Icahn School of Medicine at Mount Sinai), Gillian W. Hooker(National Institutes of Health), Alexandra Lebensohn(National Institutes of Health), Emily Dalton(Ambry Genetics (United States)), Tiffani A. DeMarco(Georgetown University), Wendy McKinnon(University of Vermont), Shelley R. McCormick(Georgetown University), Scott P. Kelly(Pfizer (United States)), Diana Moglia Tully, Marc D. Schwartz(Guardia Civil), Claire Rebecca Davis(Sarah Lawrence College), Kristi D. Graves(Georgetown University), Heiðdís Valdimarsdóttir(Reykjavík University), Jessica Heinzmann(Atlantic Health System), Morgan Similuk, Andrea Forman(Fox Chase Cancer Center)
Cited by 26
Related Papers
The Group-Based Medical Mistrust Scale: psychometric properties and association with breast cancer screening
|Preventive Medicine|2003|495
Founder and Recurrent CDH1 Mutations in Families With Hereditary Diffuse Gastric Cancer
|JAMA|2007|455
Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy
|JCI Insight|2016|304